Best Mid Cap Funds
Tomorrow's large caps. Higher growth, higher swings — reward the patient.
Data updated · 34 direct-growth funds ranked by a transparent 0–100 Smart Score
| ⚖ VS | Fund | Score ↓ | Verdict | 1Y | 3Y | 5Y | Sharpe | Sortino | Std Dev | Alpha | Beta | VR★ | P/E | Expense | AUM | Age |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Invesco India Midcap Invesco | 83 | Strong Buy | 10.3% | 23.4% | 19.3% | 0.81 | 1.37 | 20.2 | 6.7 | 1.01 | 5★ | 42.4 | 0.76% | ₹15.8k Cr | 13.9y | |
| WhiteOak Capital Mid Cap WhiteOak | 78 | Strong Buy | 8.5% | 20.0% | — | 0.82 | 1.14 | 17.6 | 5.9 | 0.90 | 5★ | 27.0 | 0.93% | ₹7.8k Cr | 4.2y | |
| HSBC Midcap HSBC | 75 | Buy | 14.7% | 21.2% | 18.4% | 0.78 | 1.05 | 20.8 | 6.3 | 1.03 | 5★ | 31.9 | 1.10% | ₹16.8k Cr | 13.9y | |
| Helios Mid Cap Helios | 75 | Buy | 8.4% | — | — | 1.01 | 1.45 | 16.4 | 6.8 | 0.95 | — | 41.2 | 0.93% | ₹2.4k Cr | 1.7y | |
| Edelweiss Midcap Edelweiss | 70 | Buy | 3.8% | 18.4% | 17.3% | 0.73 | 0.53 | 18.5 | 4.4 | 0.95 | 5★ | 30.6 | 0.69% | ₹18.7k Cr | 13.9y | |
| HDFC Mid Cap HDFC | 69 | Buy | 2.2% | 15.4% | 18.3% | 0.60 | 0.81 | 15.0 | 1.3 | 0.84 | 4★ | 26.1 | 0.74% | ₹1.01L Cr | 13.9y | |
| ICICI Pru Mid Cap ICICI Pru | 66 | Buy | 6.6% | 19.0% | 15.7% | 0.73 | 0.95 | 19.5 | 4.6 | 1.00 | 4★ | 32.3 | 1.10% | ₹7.7k Cr | 13.9y | |
| Motilal Oswal Midcap Motilal Oswal | 66 | Buy | 0.9% | 17.3% | 19.2% | 0.58 | 0.97 | 21.3 | 3.1 | 0.96 | 4★ | 29.9 | 0.93% | ₹39.6k Cr | 12.7y | |
| Nippon India Gr Mid Cap Nippon India | 65 | Buy | 4.7% | 16.3% | 16.9% | 0.62 | 0.79 | 18.4 | 2.2 | 0.95 | 4★ | 26.2 | 0.79% | ₹48.9k Cr | 13.9y | |
| Axis Midcap Axis | 63 | Buy | 7.3% | 16.5% | 12.5% | 0.65 | 0.92 | 16.5 | 2.9 | 0.83 | 4★ | 31.5 | 0.80% | ₹33.5k Cr | 13.9y | |
| Baroda BNP Paribas Mid Cap Baroda BNP Paribas | 63 | Buy | 5.1% | 15.2% | 19.5% | 0.57 | 0.76 | 15.4 | 0.8 | 0.86 | 4★ | 26.0 | 0.78% | ₹2.5k Cr | 13.9y | |
| JM Mid Cap JM | 60 | Hold | 8.6% | 17.6% | — | 0.63 | 0.83 | 19.5 | 2.9 | 0.98 | 4★ | 33.4 | 0.95% | ₹1.3k Cr | 4.0y | |
| Bandhan Midcap Bandhan | 59 | Hold | 8.9% | 17.2% | — | 0.64 | -0.45 | 19.0 | 3.1 | 0.95 | 4★ | 43.8 | 0.76% | ₹2.5k Cr | 4.3y | |
| ITI Mid Cap ITI | 57 | Hold | 4.9% | 17.1% | 15.5% | 0.64 | 0.78 | 19.7 | 2.9 | 1.02 | 4★ | 29.0 | 0.91% | ₹1.4k Cr | 5.7y | |
| Canara Robeco Mid Cap Canara Robeco | 55 | Hold | 5.7% | 16.2% | — | 0.58 | 0.81 | 17.8 | 1.6 | 0.91 | 4★ | 38.2 | 0.91% | ₹4.8k Cr | 4.0y | |
| Mahindra Manulife Mid Cap Mahindra Manulife | 55 | Hold | 4.7% | 15.8% | 16.6% | 0.56 | 0.73 | 18.2 | 1.2 | 0.95 | 4★ | 32.1 | 0.76% | ₹4.9k Cr | 8.8y | |
| Sundaram Midcap Sundaram | 54 | Hold | 1.9% | 16.3% | 15.9% | 0.62 | 0.64 | 18.0 | 2.2 | 0.94 | 3★ | 33.1 | 1.06% | ₹13.4k Cr | 13.9y | |
| Union Midcap Union | 47 | Hold | 7.5% | 15.6% | 14.4% | 0.54 | 0.72 | 17.1 | 0.3 | 0.96 | 4★ | — | 1.08% | ₹1.9k Cr | 6.7y | |
| Kotak Midcap Kotak | 47 | Hold | 3.2% | 15.5% | 15.3% | -0.17 | -0.24 | 17.4 | -0.5 | 1.01 | 4★ | 28.7 | 0.55% | ₹64.6k Cr | 13.9y | |
| Mirae Asset Midcap Mirae Asset | 46 | Hold | 3.4% | 14.8% | 14.2% | 0.51 | 0.69 | 16.2 | -0.1 | 0.92 | 3★ | 21.7 | 0.96% | ₹18.8k Cr | 7.4y | |
| Tata Mid Cap Tata | 44 | Avoid | 3.9% | 14.0% | 14.4% | 0.49 | 0.65 | 15.8 | -0.5 | 0.88 | 4★ | 33.0 | 0.84% | ₹5.7k Cr | 13.9y | |
| Bank Of India Mid Cap Bank of India | 38 | Avoid | 5.8% | 14.5% | 12.6% | 0.51 | 0.69 | 15.7 | 0.2 | 0.86 | — | 26.3 | 1.37% | ₹706 Cr | 1.3y | |
| ABSL Midcap Aditya Birla Sun Life | 37 | Avoid | 4.7% | 14.2% | 12.6% | 0.49 | 0.66 | 15.9 | -0.4 | 0.89 | — | — | 1.23% | ₹6.3k Cr | 13.9y | |
| FranklIn India Mid Cap Franklin | 35 | Avoid | -1.6% | 13.9% | 12.9% | 0.47 | 0.64 | 15.8 | -0.8 | 0.89 | 3★ | 31.5 | 1.14% | ₹11.6k Cr | 13.9y | |
| DSP Midcap DSP | 32 | Avoid | 1.4% | 12.6% | 11.3% | 0.38 | 0.52 | 15.9 | -2.1 | 0.89 | 3★ | 21.1 | 0.85% | ₹18.9k Cr | 13.9y | |
| PGIM India Midcap PGIM India | 31 | Avoid | 3.3% | 11.5% | 10.0% | 0.33 | 0.45 | 15.4 | -2.8 | 0.85 | 3★ | 27.1 | 0.72% | ₹10.2k Cr | 13.0y | |
| LIC MF Mid Cap LIC | 27 | Avoid | 4.9% | 14.2% | 12.3% | 0.46 | 0.63 | 17.0 | -0.9 | 0.95 | 3★ | 34.2 | 1.99% | ₹353 Cr | 9.8y | |
| Quant Midcap Quant | 26 | Avoid | 2.1% | 9.5% | 14.1% | — | — | — | — | — | 4★ | 29.9 | 1.21% | ₹7.5k Cr | 13.9y | |
| SBI Midcap SBI | 26 | Avoid | -0.7% | 9.2% | 11.3% | 0.20 | 0.26 | 13.6 | -4.1 | 0.75 | 2★ | 35.0 | 1.03% | ₹22.3k Cr | 13.9y | |
| UTI Midcap UTI | 18 | Avoid | 1.9% | 11.2% | 10.8% | -0.19 | -0.26 | 17.1 | -2.0 | 1.00 | 2★ | 29.9 | 1.27% | ₹11.6k Cr | 13.9y | |
| Taurus Mid Cap Taurus | 14 | Avoid | 4.9% | 10.0% | 11.9% | 0.20 | 0.26 | 18.3 | -5.6 | 0.99 | — | — | 2.36% | ₹135 Cr | 13.9y | |
| TrustMF Mid Cap Trust | 13 | Avoid | — | — | — | — | — | — | — | — | — | 40.1 | 1.91% | ₹727 Cr | 0.7y | |
| Samco Mid Cap Samco | 8 | Avoid | — | — | — | — | — | — | — | — | — | 14.8 | 1.67% | ₹75 Cr | 0.8y | |
| The Wealth Company Mid Cap The Wealth Company | 6 | Avoid | — | — | — | — | — | — | — | — | — | 30.7 | 2.26% | ₹172 Cr | 0.3y |
Mid Cap funds — quick answers
›Which is the best Mid Cap mutual fund right now?
Invesco India Midcap currently ranks #1 of 34 Mid Cap funds with a FundLens Smart Score of 83/100 (Strong Buy). It returned 23.4% over 3 years and 19.3% over 5 years at a 0.76% expense ratio (direct plan). Rankings are recomputed from data updated 20 Nov 2026.
›Which Mid Cap fund has the best risk-adjusted returns?
Helios Mid Cap leads the category on the Sortino ratio at 1.45 (Sharpe 1.01) — meaning it has delivered the most return per unit of downside risk among Mid Cap funds.
›Which Mid Cap fund has the lowest expense ratio?
Kotak Midcap charges 0.55% a year (direct plan) — the lowest in the category. Lower fees compound in your favour over long holding periods.
›Which is the smallest Mid Cap fund by AUM?
Samco Mid Cap manages ₹75 Cr, the smallest in the category. Smaller funds can be nimbler, but check track record and costs before treating size alone as an edge.
›How long should I stay invested in a Mid Cap fund?
Mid Cap funds carry very high risk, so a horizon of 7+ years is generally sensible. Tomorrow's large caps. Higher growth, higher swings — reward the patient. This is research, not investment advice.
Visitors also asked
Want these answers conversationally? Ask FundLens · New to the ratios? Sharpe vs Sortino, explained